Verdesian Life Sciences Announces Investment from AEA Investors
01/19/21, 6:24 PM
Location
Verdesian Life Sciences ("Verdesian" or the "Company"), a leading platform that develops patented biological, nutritional, fertilizer enhancers, seed treatment and inoculant technologies for high-value specialty crops, row crops, and turf and ornamental markets, today announced it has entered into a definitive stock purchase agreement with funds managed by AEA Investors LP ("AEA"). Verdesian's management team, including President and CEO Kenny Avery, will continue to lead the Company following the close of the transaction.
Company Info
Location
cary, illinois, united states
Additional Info
Founded in 2012, Verdesian Life Sciences offers patented biological, nutritional, fertilizer enhancers, seed treatment and inoculant technologies for high-value specialty crops, row crops, and turf and ornamental markets. Verdesian's plant-health products, nutritional catalysts and seed treatments/inoculants help growers farm more efficiently to maximize yields. Verdesian's technologies answer the needs facing agriculture including increasing pressures on food demand, supply and food safety. Verdesian remains committed to the research and development of environmentally sustainable products. Further information about Verdesian is available at www.vlsci.com.